Cortalix is a biotechnological company capable of developing ImmunoPET, targeted ImmunoRLT, CAR-T Immunotherapeutics and Analytical Assyas for novel targets, based on its proprietary single domain antibody (sdAb, VHH or nanobody) discovery platform, which includes multiple synthetic sdAb libraries. To know more
